The long-acting drug delivery technologies market is projected to grow at a CAGR of 13.6%, till 2035, claims Roots Analysis

The growing concern of patient non-compliance and poor adherence to conventional medication regimen has prompted various biopharmaceutical companies to leverage the expertise of players offering long-acting drug delivery technologies and services

To request quote of this report, please visit:
https://www.rootsanalysis.com/reports/long-acting-drug-delivery-market/request-quote.html

Roots Analysis is pleased to announce the publication of its recent study, titled, "Long-Acting Drug Delivery Technologies and Services Market, 2023-2035"

The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies. Amongst other elements, the report includes

1. An executive summary of the insights captured during our research. It offers a high-level view on the current state of long-acting drug delivery technologies and services market and its likely evolution in the mid-long term.
2. A general overview of long-acting drug delivery and the different types of long-acting drug delivery systems. Additionally, it highlights the underlying principles and strategies associated with long-acting drug delivery.
3. A detailed assessment of the current technology landscape of long-acting drug delivery technologies.
4. A detailed assessment of the overall service providers landscape of the companies offering contract services related to long-acting drug delivery.
5. A technology competitiveness analysis of long-acting drug delivery technologies.
6. A company competitiveness analysis of long-acting drug delivery service providers.
7. Elaborate profiles of prominent players developing technologies and offering services in the domain of long-acting drug delivery (shortlisted based on a proprietary criterion).
8. A detailed analysis of the recent partnerships inked between stakeholders engaged in this domain, since 2018.
9. A detailed analysis of over 570 peer-reviewed, scientific articles focused on research related to long-acting drug delivery.
10. An in-depth analysis of various patents that have been filed / granted related to long-acting drug delivery, since 2018.
11. A detailed review of academic grants that have been awarded to various research institutes for projects focused on long-acting drug delivery, since 2018.
12. A detailed market forecast, featuring analysis of the current and projected future opportunity across

Key market segments (listed below)

Principle
1. Manipulation of drug release from delivery systems
2. Manipulation of in vivo clearance

Strategy
1. Chemical Modification
2. Micro-encapsulation
3. Long-Acting Hydrogels
4. Long-Acting Implants
5. Long-Acting Microneedles
6. Multivesicular Liposomes
7. Nanocrystal Suspensions
8. Protein Fusion

Compatible Dosage Form
1. Injectables
2. Implantables
3. Oral Dosage Forms
4. Topical / Transdermal Dosage Forms
5. Vaginal Dosage Forms
6. Other Dosage Forms

Type of Molecules Delivered
1. Small Molecules
2. Biologics
3. Other Molecules

Type of Material Used
1. Polymer based
2. Non-polymer based

Key Geographical Regions
1. North America
2. Europe
3. Asia-Pacific
4. Middle East and North Africa

To request a sample copy / brochure of this report, please visit
https://www.rootsanalysis.com/reports/long-acting-drug-delivery-market/request-sample.html

Key companies covered in the report
1. Adare Pharma Solutions
2. AMW
3. Bostal Drug Delivery
4. Creative Biolabs
5. ForDoz Pharma
6. Innocore Pharmaceuticals
7. Integral BioSystems
8. LATITUDE Pharmaceuticals
9. Navin Saxena Research and Technology Centre (NSRT)
10. Samyang Biopharm

Browse Full Report Description + Research Methodology + Table of Content + Infographics here:
https://www.rootsanalysis.com/reports/long-acting-drug-delivery-market.html

Contact Details
Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
Website: https://www.rootsanalysis.com

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

This release was published on openPR.